10x Genomics Inc (TXG)
27.52
-0.06
(-0.22%)
USD |
NASDAQ |
Apr 24, 16:00
27.57
+0.05
(+0.18%)
After-Hours: 20:00
10x Genomics Cash from Investing (TTM): 133.49M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 133.49M |
| September 30, 2023 | 87.22M |
| June 30, 2023 | 49.69M |
| March 31, 2023 | 26.63M |
| December 31, 2022 | -350.89M |
| September 30, 2022 | -345.33M |
| June 30, 2022 | -332.93M |
| March 31, 2022 | -319.97M |
| December 31, 2021 | -106.73M |
| Date | Value |
|---|---|
| September 30, 2021 | -101.38M |
| June 30, 2021 | -82.46M |
| March 31, 2021 | -74.63M |
| December 31, 2020 | -38.39M |
| September 30, 2020 | -22.71M |
| June 30, 2020 | -35.08M |
| March 31, 2020 | -41.48M |
| December 31, 2019 | -42.77M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-350.89M
Minimum
Dec 2022
133.49M
Maximum
Dec 2023
-93.98M
Average
-42.77M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
| Teladoc Health Inc | -156.35M |
| American Shared Hospital Services | -6.273M |
| Novo Integrated Sciences Inc | -- |
| Astrana Health Inc | -65.52M |
| Cryo-Cell International Inc | -7.284M |